
|Articles|January 23, 2019
Costs for glaucoma interventions
Author(s)Doug Katsev, MD
How affordable are glaucoma interventions in developed and developing countries? Doug Katsev, MD, takes a look.
Advertisement
How affordable are glaucoma interventions in developed and developing countries? Doug Katsev, MD, takes a look.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
First patient treated in ViaLase’s IDE trial
2
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
3
Formosa Pharmaceuticals and Rxilient sign licensing and commercialization agreement for APP13007
4
PainReform launches development plan for OcuRing-K, readies phase 2 trial
5















































.png)


